Establishment of a PCR analysis method for canine BRCA2
Yasunaga Yoshikawa1, Masami Morimatsu, Kazuhiko Ochiai
1Laboratory of Veterinary Biochemistry, School of Veterinary Medicine, Kitasato University, Aomori 034-8628, Japan. yyoshika@vmas.kitasato-u.ac.jp
BMC Research Notes
|April 5, 2012
Summary
Researchers developed new methods to analyze the canine BRCA2 gene, crucial for understanding its link to mammary tumors in dogs. This work establishes a consensus sequence and detects splicing variants, aiding future cancer risk studies.
Area of Science:
- Canine genetics
- Comparative oncology
- Molecular biology
Background:
- Mammary tumors are common in female dogs and humans.
- BRCA2 gene mutations increase breast cancer risk in women.
- The role of canine BRCA2 in mammary tumors is unclear due to a lack of established sequencing and mutation detection methods.
Purpose of the Study:
- To establish methods for analyzing canine BRCA2.
- To define the consensus canine BRCA2 open reading frame (ORF) sequence.
- To develop a method for detecting canine BRCA2 splicing variants.
Main Methods:
- Designed PCR primer sets for canine BRCA2 ORF and exons.
- Sequenced full-length canine BRCA2 ORF from healthy dogs.
- Sequenced partial BRCA2 genomic DNA from tumor-free dogs.
- Compared sequences to define the consensus canine BRCA2 ORF.
- Established a splicing variant detection method.
Main Results:
- Developed methods for canine BRCA2 sequencing and variant detection.
- Defined the consensus canine BRCA2 ORF sequence.
- Identified novel splicing variants in normal canine testes.
Conclusions:
- Established methods are valuable for studying canine BRCA2.
- These methods will improve understanding of canine BRCA2 mutation status and cancer risk.
